150 related articles for article (PubMed ID: 32885235)
1. Cutaneous Involvement in Plasma Cell Myeloma.
Panse G; Subtil A; McNiff JM; Glusac EJ; Ko CJ; Galan A; Myung P; Xu ML
Am J Clin Pathol; 2021 Jan; 155(1):106-116. PubMed ID: 32885235
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases.
Requena L; Kutzner H; Palmedo G; Calonje E; Requena C; Pérez G; Pastor MA; Sangueza OP
Arch Dermatol; 2003 Apr; 139(4):475-86. PubMed ID: 12707095
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
Abdalla S; May PC; Garimberti E; Naresh KN
Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
[No Abstract] [Full Text] [Related]
5. Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.
Ioannou MG; Stathakis E; Lazaris AC; Papathomas T; Tsiambas E; Koukoulis GK
Pathol Oncol Res; 2009 Mar; 15(1):25-9. PubMed ID: 18553158
[TBL] [Abstract][Full Text] [Related]
6. [Specific cutaneous involvement in patients with multiple myeloma. A clinicopathological, immunohistochemical and cytogenetic study of 40 cases].
Requena L
Actas Dermosifiliogr; 2005 Sep; 96(7):424-40. PubMed ID: 16476270
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Myeloma Mimicking Metastatic Carcinoma with CD138 positivity: a Potential Diagnostic Pitfall.
Wang H; Zhang J; He C; Peng F; Liu Z; Xiao D
Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254033
[TBL] [Abstract][Full Text] [Related]
8. [The clinic and pathologic significance of plasma cell myeloma with CCND1].
Sun Q; An G; Liu E; Li Z; Zhang H; Yang Q; Sun F; Ma Y; Xian M; Zhang P; Ru K
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):775-9. PubMed ID: 26462780
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic characteristics of plasma cell myeloma with marrow fibrosis].
Li HL; Ru K; Sun Q; Li ZQ; Zhang HJ; Ma Y; Xian M; Qiu LG; Liu EB
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):327-331. PubMed ID: 28468039
[No Abstract] [Full Text] [Related]
10. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
[TBL] [Abstract][Full Text] [Related]
12. Plasmablastic transformation of multiple myeloma.
Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
[TBL] [Abstract][Full Text] [Related]
13. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
Cogbill CH; Spears MD; Vantuinen P; Harrington AM; Olteanu H; Kroft SH
Int J Lab Hematol; 2015 Dec; 37(6):797-808. PubMed ID: 26224420
[TBL] [Abstract][Full Text] [Related]
14. CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.
Olteanu H; Harrington AM; Kroft SH
Am J Clin Pathol; 2012 Dec; 138(6):867-76. PubMed ID: 23161721
[TBL] [Abstract][Full Text] [Related]
15. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma.
Dunphy CH; Nies MK; Gabriel DA
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):248-54. PubMed ID: 17721267
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study of cutaneous plasmacytoma.
Torne R; Su WP; Winkelmann RK; Smolle J; Kerl H
Int J Dermatol; 1990 Oct; 29(8):562-6. PubMed ID: 2242944
[TBL] [Abstract][Full Text] [Related]
17. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
Liu Y; Jelloul F; Zhang Y; Bhavsar T; Ho C; Rao M; Lewis NE; Cimera R; Baik J; Sigler A; Sen F; Yabe M; Roshal M; Landgren O; Dogan A; Xiao W
Am J Surg Pathol; 2020 Jun; 44(6):838-848. PubMed ID: 32118627
[TBL] [Abstract][Full Text] [Related]
18. IgM multiple myeloma: pathologic evaluation of a rare entity.
King RL; Howard MT; Hodnefield JM; Morice WG
Am J Clin Pathol; 2013 Oct; 140(4):519-24. PubMed ID: 24045549
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.
Athanasiou E; Kaloutsi V; Kotoula V; Hytiroglou P; Kostopoulos I; Zervas C; Kalogiannidis P; Fassas A; Christakis JI; Papadimitriou CS
Am J Clin Pathol; 2001 Oct; 116(4):535-42. PubMed ID: 11601138
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotype of neoplastic plasma cells in AL amyloidosis.
Deshmukh M; Elderfield K; Rahemtulla A; Naresh KN
J Clin Pathol; 2009 Aug; 62(8):724-30. PubMed ID: 19638544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
